Search bioRxiv⌕ Search

Biology subjects

Raszka, K.

Publications and source records attributed to Raszka, K..

2 recordsLinked to original sources
bioRxiv2026

An Effective Metal Nanoparticle-Based Drug Delivery System for an In Vitro Model of Non Small Cell Lung Cancer

This study presents the development and spectroscopic characterization of an erlotinib-functionalized gold nanoparticle (erlotinib:AuNP) nanosystem designed for targeted delivery to metastatic non-small cell lung cancer H1299 cells. Initial MTS assays demonstrated that free erlotinib induced a concentration-dependent reduction in cell viability, while 0.1 {micro}M erlotinib exhibited negligible cytotoxicity and was therefore selected for nanosystem fabrication. AuNPs alone showed minimal toxicity toward H1299 cells over the investigated concentration range. Following conjugation of erlotinib with AuNPs, the resulting nanosystems reduced cell viability to approximately 60%, indicating enhanced biological activity of the drug after nanoparticle-assisted delivery. Fluorescence microscopy confirmed the intracellular internalization of the nanosystems in H1299 cells, with nanoparticle aggregates predominantly localized in the perinuclear and perimitochondrial regions. Three-dimensional Raman spectroscopy (3D RS) mapping further verified the intracellular localization of the conjugates through characteristic Raman signatures of erlotinib:AuNPs. Importantly, 3D RS enabled detection of nanosystems at concentrations below the sensitivity limit of fluorescence imaging, demonstrating superior analytical performance for intracellular nanosystem tracking. Atomic force microscopy-infrared (AFM-IR) spectroscopy coupled with principal component analysis (PCA) demonstrated substantial biochemical modifications induced by the erlotinib:AuNP nanosystems, including enhanced lipid-related spectral features and significant alterations in protein secondary structure, particularly the increased contribution of unordered and antiparallel {beta}-turn conformations. The obtained results demonstrate that combining plasmonic nanocarriers with advanced vibrational spectroscopy enables highly sensitive monitoring of intracellular drug delivery and nanosystem-induced biochemical responses in cancer cells.

biophysics↗
bioRxiv2026

Drug Affinity and Functionalization of Gold Nanoparticles: AFMSEIRA and SERS Study

This study presents the first investigation of the adsorption behaviour of Afatinib on gold nanoparticle (AuNP) monolayers, employing a combination of AFM-SEIRA and SERS techniques. Two types of AuNPs with distinct sizes, synthesized using different reagents, were employed to elucidate the influence of surface type on drug adsorption. The first type of AuNPs was synthesized using sodium borohydride (SB), whereas the second type was obtained using hydroxylamine hydrochloride (HH) as the reducing agent. AFM-SEIRA revealed that Afatinib interacts to the AuNPs primarily through the quinazoline ring, amide group, and amino moiety, with adsorption geometry strongly dependent on nanoparticle type. Contributions from CH3 and CH2 moieties were also identified, indicating their role in stabilizing the molecule/metal interface. Time-resolved SERS studies demonstrated that the adsorption process is dynamic and involves molecular reorientation, followed by gradual desorption, which is accelerated at physiological temperature (37 {degrees}C). Competitive adsorption experiments with phenylboronic acid (PBA) showed that Afatinib exhibits higher affinity toward AuNPs, however, co-adsorption leads to reduced stability of both species on the surface. The results reveal molecular insights into drug/nanoparticle interactions and emphasize the role of surface functionalization in efficient nanocarrier design. This work deepens understanding of adsorption at plasmonic interfaces for biomedical use.

biophysics↗